The review for accreditation as a “compliant organization for medical safety evaluation” has been completed.
AS A “PHYSICIAN-GUIDED CLINICAL TRIAL”, OUR RESEARCH GROUP HAS CONDUCTED INTESTINAL FLORA TRANSPLANTATION (FECAL MICROBIOTA TRANSPLANTATION = FMT) FOR THE FIRST TIME IN JAPAN IN 2017 AT A PRIVATE MEDICAL INSTITUTION IN AN ORGANIZED MANNER TO ESTABLISH A NEW MEDICAL TREATMENT.
The patients who received intestinal flora transplants, which had not yet been established as a medical treatment, in anticipation of the potential of intestinal bacteria, and the clinicians who came together with the passion that the current treatment alone could not solve their patients’ problems, gradually gained recognition and support.
We are pleased to report that we have applied to the Ethics Review Committee of the Japan Organization for Clinical Research Safety Evaluation and have officially completed the review process for accreditation as a “compliant organization for medical safety evaluation”.
In the future, the treatment will be recognized as a more reliable treatment by submitting a notification to the Ethics Review Committee for each disease.
We would appreciate your continued support for the further dissemination of our FMT using the NanoGAS® technology.

その他の Notices and Activity Reports に関する記事
Articles about other Notices and Activity Reports

October 06, 2026
Survey Summary from the 10th Annual Academic Conference
The 10th Annual Academic Conference was held on September 27, 2026.The event was conducted in a hybrid format, both on-site and online, with close to 150 participants in total, including healthcare professionals, corporate representatives, research institution staff, and even patients, their families, and members of the general public. In this article, we share the results […]

September 28, 2026
10th Scientific Conference of the Association for Clinical Research of Fecal Microbiota Transplantation Japan [Event Report]
The Association for Clinical Research of Fecal Microbiota Transplantation Japan (General Incorporated Foundation) held its 10th Scientific Conference on Sunday, 27 September 2026. At this milestone 10th conference, we presented the latest findings and clinical data on “NanoGAS®-FMT” across a wide range of clinical fields, including cancer, gastroenterology, neurodevelopmental disorders and endoscopic examinations, for those […]

October 28, 2024
〈Clinical Trial〉Completion Report
We are pleased to report the completion of the specified clinical trial titled “Specified Clinical Trial on the Efficacy and Safety of a Novel Fecal Microbiota Transplantation Method for Autism Spectrum Disorder,” which was initiated by our research group in May 2023. This specified clinical trial is published on the jRCT (Japan Registry of Clinical […]